Skip to main content

Advertisement

SpringerLink
Log in

Progression of myeloproliferative neoplasm with BCR::JAK2 fusion to acute leukemia of ambiguous lineage

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Khoury JD, Solary E, Abla O, Akkari Y, Alaggio R et al (2022) The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms. Leukemia 36(7):1703–1719. https://doi.org/10.1038/s41375-022-01613-1

    Article  PubMed  PubMed Central  Google Scholar 

  2. Arber DA, Orazi A, Hasserjian RP, Borowitz MJ, Calvo KR et al (2022) International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data. Blood 140(11):1200–1228. https://doi.org/10.1182/blood.2022015850

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Schwaab J, Knut M, Haferlach C, Metzgeroth G, Horny HP et al (2015) Limited duration of complete remission on ruxolitinib in myeloid neoplasms with PCM1-JAK2 and BCR-JAK2 fusion genes. Ann Hematol 94(2):233–238. https://doi.org/10.1007/s00277-014-2221-y

    Article  CAS  PubMed  Google Scholar 

  4. Metzgeroth G, Steiner L, Naumann N, Lübke J, Kreil S et al (2023) Myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions: reevaluation of the defining characteristics in a registry-based cohort. Leukemia. https://doi.org/10.1038/s41375-023-01958-1

    Article  PubMed  PubMed Central  Google Scholar 

  5. He R, Greipp PT, Rangan A, Mai M, Chen D et al (2016) BCR-JAK2 fusion in a myeloproliferative neoplasm with associated eosinophilia. Cancer Genet 209(5):223–228. https://doi.org/10.1016/j.cancergen.2016.03.002

    Article  CAS  PubMed  Google Scholar 

  6. Tang G, Sydney Sir Philip JK, Weinberg O, Tam W, Sadigh S et al (2019) Hematopoietic neoplasms with 9p24/JAK2 rearrangement: a multicenter study. Mod Pathol 32(4):490–498. https://doi.org/10.1038/s41379-018-0165-9

    Article  CAS  PubMed  Google Scholar 

  7. Reiter A, Gotlib J (2017) Myeloid neoplasms with eosinophilia. Blood 129(6):704–714. https://doi.org/10.1182/blood-2016-10-695973

    Article  CAS  PubMed  Google Scholar 

  8. Pozdnyakova O, Orazi A, Kelemen K, King R, Reichard KK et al (2021) Myeloid/lymphoid neoplasms associated with eosinophilia and rearrangements of PDGFRA, PDGFRB, or FGFR1 or with PCM1-JAK2. Am J Clin Pathol 155(2):160–178. https://doi.org/10.1093/ajcp/aqaa208

    Article  CAS  PubMed  Google Scholar 

  9. Schwaab J, Naumann N, Luebke J, Jawhar M, Somervaille TCP et al (2020) Response to tyrosine kinase inhibitors in myeloid neoplasms associated with PCM1-JAK2, BCR-JAK2 and ETV6-ABL1 fusion genes. Am J Hematol 95(7):824–833. https://doi.org/10.1002/ajh.25825

    Article  CAS  PubMed  Google Scholar 

  10. Lane SW, Fairbairn DJ, McCarthy C, Nandini A, Perry-Keene J et al (2008) Leukaemia cutis in atypical chronic myeloid leukaemia with a t(9;22) (p24;q11.2) leading to BCR-JAK2 fusion. Br J Haematol 142(4):503. https://doi.org/10.1111/j.1365-2141.2008.07164.x

    Article  PubMed  Google Scholar 

  11. Iacobucci I, Witkowski MT, Mullighan CG (2023) Single-cell analysis of acute lymphoblastic and lineage-ambiguous leukemia: approaches and molecular insights. Blood 141(4):356–368. https://doi.org/10.1182/blood.2022016954

    Article  CAS  PubMed  Google Scholar 

  12. Tzankov A, Reichard KK, Hasserjian RP, Arber DA, Orazi A et al (2023) Updates on eosinophilic disorders. Virchows Arch 482(1):85–97. https://doi.org/10.1007/s00428-022-03402-8

    Article  CAS  PubMed  Google Scholar 

  13. Chamseddine AN, Etancelin P, Penther D, Parmentier F, Kuadjovi C et al (2015) Transformation of an unclassified myeloproliferative neoplasm with a rare BCR-JAK2 fusion transcript resulting from the translocation (9;22)(p24;q11). Case Rep Hematol 2015:252537. https://doi.org/10.1155/2015/252537

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Bain BJ, Ahmad S (2014) Should myeloid and lymphoid neoplasms with PCM1-JAK2 and other rearrangements of JAK2 be recognized as specific entities? Br J Haematol 166(6):809–817. https://doi.org/10.1111/bjh.12963

    Article  CAS  PubMed  Google Scholar 

  15. Chen JA, Hou Y, Roskin KM, Arber DA, Bangs CD et al (2021) Lymphoid blast transformation in an MPN with BCR-JAK2 treated with ruxolitinib: putative mechanisms of resistance. Blood Adv 5(17):3492–3496. https://doi.org/10.1182/bloodadvances.2020004174

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Tefferi A, Alkhateeb H, Gangat N (2023) Blast phase myeloproliferative neoplasm: contemporary review and 2024 treatment algorithm. Blood Cancer J 13(1):108. https://doi.org/10.1038/s41408-023-00878-8

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hematology, Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid, Madrid, Spain

    Edwin Uriel Suárez, José Luis López-Lorenzo, Javier Cornago-Navascués, Rocío Salgado-Sánchez, Tamara Castaño-Bonilla, Raquel Mata-Serna, Juan M. Alonso-Domínguez & Pilar Llamas

  2. Department of Pathology, Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid, Madrid, Spain

    Miguel Ángel Piris & Socorro María Rodríguez-Pinilla

  3. Department of Pathology, MD Anderson Cancer Center, Madrid, Spain

    Juan F. García

Authors
  1. Edwin Uriel Suárez
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Miguel Ángel Piris
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Socorro María Rodríguez-Pinilla
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Juan F. García
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. José Luis López-Lorenzo
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Javier Cornago-Navascués
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Rocío Salgado-Sánchez
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Tamara Castaño-Bonilla
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Raquel Mata-Serna
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Juan M. Alonso-Domínguez
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Pilar Llamas
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All authors wrote and edited the manuscript.

Corresponding author

Correspondence to Edwin Uriel Suárez.

Ethics declarations

Consent to participate

The patient’s consent was obtained.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Suárez, E.U., Piris, M.Á., Rodríguez-Pinilla, S.M. et al. Progression of myeloproliferative neoplasm with BCR::JAK2 fusion to acute leukemia of ambiguous lineage. Ann Hematol 103, 1797–1799 (2024). https://doi.org/10.1007/s00277-024-05647-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-024-05647-6

Search

Navigation